Advertisement

Topic - Emergent Biosolutions

Related Stories

Robert Kramer, president and chief executive officer of Emergent BioSolutions, speaks via videoconference during a House Select Subcommittee on the Coronavirus Crisis hearing on Capitol Hill in Washington, Wednesday, May 19, 2021, examining Emergent BioSolutions, a Maryland biotech firm whose Baltimore plant ruined millions of doses of the coronavirus vaccine. (Stefani Reynolds/The New York Times via AP, Pool)

House panel alleges cover-up by contract vaccine manufacturer

Associated Press

FILE - In this April 8, 2021 file photo, the Johnson &amp; Johnson COVID-19 vaccine is seen at a pop up vaccination site in the Staten Island borough of New York. The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine bulk substance to resume, the company said Thursday, July 29. The Baltimore factory was shut down by the FDA in mid-April due to contamination problems that forced the company to trash the equivalent of tens of millions of doses of vaccine it was making under contract for Johnson &amp; Johnson. (AP Photo/Mary Altaffer, File)

Emergent: FDA letting troubled COVID vaccine factory restart

By Linda A. Johnson - Associated Press

This Saturday, March 6, 2021 file photo shows vials of Johnson & Johnson COVID-19 vaccine at a pharmacy in Denver. On Thursday, June 10, 2021, Johnson & Johnson said that the U.S. Food and Drug Administration extended the expiration date on millions of doses of its COVID-19 vaccine by an extra six weeks. (AP Photo/David Zalubowski, File) **FILE**

FDA clears release of J&J vaccine from troubled Baltimore factory

By Shen Wu Tan - The Washington Times

Robert Kramer, president and chief executive officer of Emergent BioSolutions, speaks via videoconference during a House Select Subcommittee on the Coronavirus Crisis hearing on Capitol Hill in Washington, Wednesday, May 19, 2021, examining Emergent BioSolutions, a Maryland biotech firm whose Baltimore plant ruined millions of doses of the coronavirus vaccine. (Stefani Reynolds/The New York Times via AP, Pool)

Emergent BioSolutions CEO: We take ‘full responsibility’ for vaccine mishap

By Tom Howell Jr. - The Washington Times

House Majority Whip James E. Clyburn, D-S.C., and Chairman of the House Select Subcommittee on the Coronavirus Crisis speaks during a hearing on Capitol Hill in Washington, Thursday, April 15, 2021, on the coronavirus crisis. (AP Photo/Susan Walsh, Pool) **FILE**

Emergent BioSolutions execs to testify before House panel

By Tom Howell Jr. - The Washington Times

A family attends the burial service for David Ferreira Gomes, who died from complications related to COVID-19, at the Campo da Esperanca cemetery in Brasilia, Brazil, Friday, April 16, 2021. Brazil marked a milestone of 400,000 COVID-19 deaths Thursday, April 29, 2021, the world's second-highest tally, with the majority recorded in just the last four months. (AP Photo/Eraldo Peres)

The Latest: Canada puts J&J vaccine rollout plans on hold

By The Associated Press - Associated Press

In this March 26, 2021, file photo a member of the Philadelphia Fire Department prepares a dose of the Johnson & Johnson COVID-19 vaccine at a vaccination site setup in Philadelphia. (AP Photo/Matt Rourke, File)

J&J, Emergent stocks slide amid COVID-19 vaccine mix-up

By Tom Howell Jr. - The Washington Times

In this March 25, 2021, file photo, a box of the Johnson &amp; Johnson COVID-19 vaccine is shown in a refrigerator at a clinic in Washington state. A batch of Johnson &amp; Johnson’s COVID-19 vaccine failed quality standards and can’t be used, the drug giant said late Wednesday, March 31, 2021. The drugmaker didn’t say how many doses were lost, and it wasn’t clear how the problem would impact future deliveries. (AP Photo/Ted S. Warren)

Company producing J&J vaccine had history of violations

By RICHARD LARDNER and JASON DEAREN and LINDA A. JOHNSON - Associated Press

FILE - In this Thursday, Sept. 12, 2019 file photo, a police officer holds a box of Narcan, a drug used to treat opioid overdoses, that the department officers carry in their patrol vehicles in Jackson Township, Butler County, Pa. More companies could begin making the easy-to-use version of the medication under a deal announced Thursday, Jan. 2, 2020 by New York's attorney general. (AP Photo/Keith Srakocic)

Deal will let more companies make an overdose antidote spray

Associated Press